Jorge Santos da Silva
2022
In 2022, Jorge Santos da Silva earned a total compensation of $4.5M as Chief Executive Officer at MoonLake Immunotherapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Bonus | $632,878 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $30,404 |
| Salary | $460,275 |
| Stock Awards | $3,362,817 |
| Other | $21,411 |
| Total | $4,507,785 |
Silva received $3.4M in stock awards, accounting for 75% of the total pay in 2022.
Silva also received $632.9K in bonus, $30.4K of change in pension value and nonqualified deferred compensation earnings, $460.3K in salary and $21.4K in other compensation.
Rankings
In 2022, Jorge Santos da Silva's compensation ranked 729th out of 5,760 executives tracked by ExecPay. In other words, Silva earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 729 out of 5,760 | 87th |
Division Manufacturing | 324 out of 3,136 | 90th |
Major group Chemicals And Allied Products | 104 out of 1,422 | 93rd |
Industry group Drugs | 91 out of 1,323 | 93rd |
Industry Pharmaceutical Preparations | 68 out of 969 | 93rd |
Source: SEC filing on April 26, 2023.
Silva's colleagues
We found two more compensation records of executives who worked with Jorge Santos da Silva at MoonLake Immunotherapeutics in 2022.